IRIS Accounts Production v26.1.10.60 05591371 Board of Directors Board of Directors 1.1.25 31.12.25 31.12.25 28.4.26 false true false false true false Auditors Opinion Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh055913712024-12-31055913712025-12-31055913712025-01-012025-12-31055913712023-12-31055913712024-01-012024-12-31055913712024-12-3105591371ns15:EnglandWales2025-01-012025-12-3105591371ns14:PoundSterling2025-01-012025-12-3105591371ns10:Director12025-01-012025-12-3105591371ns10:Director22025-01-012025-12-3105591371ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3105591371ns10:SmallEntities2025-01-012025-12-3105591371ns10:Audited2025-01-012025-12-3105591371ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3105591371ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3105591371ns10:FullAccounts2025-01-012025-12-3105591371ns10:OrdinaryShareClass12025-01-012025-12-3105591371ns5:CurrentFinancialInstruments2025-12-3105591371ns5:CurrentFinancialInstruments2024-12-3105591371ns5:ShareCapital2025-12-3105591371ns5:ShareCapital2024-12-3105591371ns5:RetainedEarningsAccumulatedLosses2025-12-3105591371ns5:RetainedEarningsAccumulatedLosses2024-12-3105591371ns5:PlantMachinery2025-01-012025-12-3105591371ns5:ComputerEquipment2025-01-012025-12-3105591371ns5:PlantMachinery2024-12-3105591371ns5:ComputerEquipment2024-12-3105591371ns5:PlantMachinery2025-12-3105591371ns5:ComputerEquipment2025-12-3105591371ns5:PlantMachinery2024-12-3105591371ns5:ComputerEquipment2024-12-3105591371ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3105591371ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3105591371ns10:OrdinaryShareClass12025-12-31
REGISTERED NUMBER: 05591371 (England and Wales)















Financial Statements for the Year Ended 31 December 2025

for

CELLULAR TECHNOLOGY EUROPE LIMITED

CELLULAR TECHNOLOGY EUROPE LIMITED (REGISTERED NUMBER: 05591371)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Statement of Financial Position 1

Notes to the Financial Statements 2


CELLULAR TECHNOLOGY EUROPE LIMITED (REGISTERED NUMBER: 05591371)

Statement of Financial Position
31 December 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 1,234 1,796

CURRENT ASSETS
Stocks 100,743 315,310
Debtors 6 116,620 143,698
Cash at bank 145,777 75,106
363,140 534,114
CREDITORS
Amounts falling due within one year 7 28,919 156,938
NET CURRENT ASSETS 334,221 377,176
TOTAL ASSETS LESS CURRENT
LIABILITIES

335,455

378,972

PROVISIONS FOR LIABILITIES 234 -
NET ASSETS 335,221 378,972

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Retained earnings 334,221 377,972
SHAREHOLDERS' FUNDS 335,221 378,972

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 April 2026 and were signed on its behalf by:




J Hickl - Director



Mr D Spicher - Director


CELLULAR TECHNOLOGY EUROPE LIMITED (REGISTERED NUMBER: 05591371)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Cellular Technology Europe Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 05591371 and the registered office address is 7 Marconi Gate, Staffordshire Technology Park, Stafford, Staffordshire, ST18 0FZ. The business trading address is Suite 6, 35 Lonsdale Road, Harborne, Birmingham. B17 9RA.

The presentation of the financial statements is the Pound Sterling (£).

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared on the going concern basis and under the historical cost convention.

Significant judgements and estimates
The preparation of the financial statements in conformity with generally accepted accounting principles requires the Directors to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results in the future could differ from those estimates. Management considers that certain accounting assumptions relating to revenue, taxation, stock and provisions are its critical accounting policies.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover is recognised when the goods are physically delivered to the customer.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 33% on reducing balance

Stocks
Stock is valued at the lower of cost and net realisable value. Cost is determined on a first in first out basis. Net realisable value represents estimated selling price less costs to complete to sell. Provision is made for slow moving, obsolete or damaged stock where the net realisable value is less than cost.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

CELLULAR TECHNOLOGY EUROPE LIMITED (REGISTERED NUMBER: 05591371)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

3. ACCOUNTING POLICIES - continued

Going concern
Brexit continues to have only minor impact on the business, as stock is based in The Netherlands (Rapid Logistics) and UK customer base is very small.
The 2025 results for Cellular Technology Europe were below 2024 results and 2025 forecast due to major supply issues for Celltech 52, 60 and 66.
An alternative producer for Celltech 50 and 52 has been found. Celltech 50 was provided in 2026 quarter one and we are confident that orders for Celltech 52 will be made in quarter two, which should bring turnover levels back to earlier years.

The directors do not consider that a material uncertainty about the going concern status exists. The company has continued to prepare the accounts on a going concern basis and deem this to be appropriate.
In making this assessment the directors have considered the likely trading conditions for a period of twelve months from approval of these accounts.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 1 ) .

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 January 2025
and 31 December 2025 14,174 5,329 19,503
DEPRECIATION
At 1 January 2025 13,112 4,595 17,707
Charge for year 265 297 562
At 31 December 2025 13,377 4,892 18,269
NET BOOK VALUE
At 31 December 2025 797 437 1,234
At 31 December 2024 1,062 734 1,796

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade debtors 107,809 135,114
Other debtors 7,238 7,020
VAT 609 542
Prepayments 964 1,022
116,620 143,698

CELLULAR TECHNOLOGY EUROPE LIMITED (REGISTERED NUMBER: 05591371)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade creditors 16,476 110,447
Taxation (4,243 ) -
Social security and other taxes 2,095 3,421
Accrued expenses 14,591 43,070
28,919 156,938

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.25 31.12.24
value: £    £   
1,000 Ordinary £1 1,000 1,000

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Adele Lawton (Senior Statutory Auditor)
for and on behalf of Lawton Bradford Accountants Ltd

10. OTHER FINANCIAL COMMITMENTS

The company has future operating lease commitments of £1,916.71 (2024: £13,416.67) of which £1,916.71 (2024: £11,500) is due within one year.

11. RELATED PARTY DISCLOSURES

During the year, the company sold goods totalling £Nil (2024 - £Nil) and purchased goods totalling £116,782.42 (2024 - £192,495.26) from Cellular Technology International Inc (incorporated in the USA), the parent company. As at the 31 December 2025 £276.80 (2024 - £28,226) was due to Cellular Technology International Inc, the parent company.

Transactions between Cellular Technology Europe Limited and Cellular Technology International Inc are conducted on commercial terms at arms length prices.

12. ULTIMATE CONTROLLING PARTY

The controlling party is Cellular Technology International Inc.

Cellular Technology International Inc, is the parent company and is registered in the USA. The registered office and principal place of business is 1690 Roberts Blvd, Suite 118 Kennesaw, Georgia 30144, USA.